SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-081538
Filing Date
2021-06-15
Accepted
2021-06-15 16:46:23
Documents
1
Group Members
ANTOINE PAPIERNIKDENIS LUCQUINGRAZIANO SEGHEZZIHENRIJETTE RICHTERMONIQUE SAULNIERSOFINNOVA PARTNERS SAS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2119779d1_sc13da.htm SC 13D/A 145864
  Complete submission text file 0001104659-21-081538.txt   147618
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Filed by) CIK: 0001441261 (see all company filings)

IRS No.: 000000000 | State of Incorp.: XX
Type: SC 13D/A

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90138 | Film No.: 211019099
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences